Getting eczema treatment covered: prior authorization and appeals

Why the first answer is often “no” (or “not yet”)

When a treatment is expensive — especially a biologic injection or an oral JAK inhibitor — insurers commonly put two hurdles in front of it. Neither is a judgment of you; both are administrative steps you can work through.

• Prior authorization — your insurer wants to approve the medication before they will cover it, usually asking your doctor for paperwork first.
• Step therapy (“fail first”) — the plan may require you to have already tried, and not done well on, one or more lower-cost treatments before it will cover the pricier one.

This is common: in a US survey of eczema patients, biologics were delayed or denied more often than any other eczema treatment, and step therapy was among the most frequent reasons given for a denial.^[1] If it has happened to you, the system is working the way it usually does — frustrating, but navigable.

You have the right to appeal — and many people don’t know it

A denial is not the last word. Under US law, if a plan denies coverage you generally have the right to two levels of review:^[2][3]

• Internal appeal — you ask the insurer to reconsider. There is usually a deadline (often around 180 days from the date on the denial notice), so it helps to act promptly.
• External review — if the internal appeal is denied, an independent third party (not your insurer) can review the decision. This is a protection under the Affordable Care Act for many plans.

What actually helps: your own treatment history

Because of step therapy, an appeal often turns on one simple thing — showing what you have already tried. That record is yours: which treatments you used, how long you used them, and why each one stopped (it didn’t work, or it caused a side effect). You have lived this history; the hard part is having it written down, clearly and in order.

Two boundaries worth knowing, because they keep you on solid ground:

• Your doctor makes the medical case. The letter of medical necessity — the document that explains, in clinical terms, why you need this treatment — is written and signed by your doctor, not by you and not by an app. Your job is to hand them a complete, organized history so they can write it well.
• General rights and process are public information (see the official links below). But how the rules apply to your specific plan is answered by your plan documents and your insurer — and, if you want an advocate, a licensed professional.

Cost help while you sort it out

Please don’t go without a needed treatment in silence while an appeal is pending. Real help exists:

• Manufacturer copay cards can lower out-of-pocket cost for people with commercial insurance. Note: by federal rule these generally cannot be used with government insurance such as Medicare or Medicaid.
• Patient-assistance programs from drug makers provide free or low-cost medicine to those who qualify — ask your doctor’s office or the manufacturer.
• Nonprofits such as the Patient Advocate Foundation and directories like NeedyMeds help people find assistance and understand their options.
• Tell your doctor cost is a barrier. It is a normal conversation, and they can often help — a different option, a sample, or a pointer to assistance.

Where to get official, free help

These are the authoritative sources. We point you to them; we don’t replace them.

• HealthCare.gov — how to appeal an insurance company decision, in plain language.^[2]
• CMS (Centers for Medicare & Medicaid Services) — appealing health plan decisions and external review.^[3]
• Your state Department of Insurance — oversees external review and takes complaints if a plan isn’t following the rules.
• The National Eczema Association — insurance and financial resources specific to eczema.^[4]

The takeaway

A “no” is very often a “not yet.” Know that you can appeal, keep the denial letter and its deadline, bring your doctor a clear record of what you’ve tried, and use the cost help that exists. You don’t have to be a lawyer or an expert — you have to be organized and persistent, and you have the right to be both.

Sources

• [1] Chiesa Fuxench ZC, et al. Patient-reported barriers to accessing atopic dermatitis care. PMC11264656.
• [2] HealthCare.gov. Appeal an insurance company decision.
• [3] Centers for Medicare & Medicaid Services. Appealing health plan decisions.
• [4] National Eczema Association. Insurance & financial resources.

More Ollowen guides: see all →